229 related articles for article (PubMed ID: 21830407)
1. Influence of preoperative transarterial chemoembolization on the prognosis for patients with resectable hepatocellular carcinoma: a meta-analysis of randomized trials.
Wang X; Li J; Peng Y; Dai Y; Xu W
Hepatogastroenterology; 2011; 58(107-108):869-74. PubMed ID: 21830407
[TBL] [Abstract][Full Text] [Related]
2. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
[TBL] [Abstract][Full Text] [Related]
3. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
4. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
Zhou WP; Lai EC; Li AJ; Fu SY; Zhou JP; Pan ZY; Lau WY; Wu MC
Ann Surg; 2009 Feb; 249(2):195-202. PubMed ID: 19212170
[TBL] [Abstract][Full Text] [Related]
6. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction.
Kaibori M; Tanigawa N; Matsui Y; Saito T; Uchida Y; Ishizaki M; Tanaka H; Kamiyama Y
Anticancer Res; 2006; 26(5B):3685-92. PubMed ID: 17094386
[TBL] [Abstract][Full Text] [Related]
7. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
10. Clinical study of transarterial chemoembolization combined with 3-dimensional conformal radiotherapy for hepatocellular carcinoma.
Xu LT; Zhou ZH; Lin JH; Chen Z; Wang K; Wang P; Zhu XY; Shen YH; Meng ZQ; Liu LM
Eur J Surg Oncol; 2011 Mar; 37(3):245-51. PubMed ID: 21195578
[TBL] [Abstract][Full Text] [Related]
11. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
Guo RP; Yu WS; Wei W
Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
[TBL] [Abstract][Full Text] [Related]
12. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?
Pérez Saborido B; Meneu JC; Moreno E; García I; Moreno A; Fundora Y
Am J Surg; 2005 Sep; 190(3):383-7. PubMed ID: 16105523
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
[TBL] [Abstract][Full Text] [Related]
14. Chemoembolization and bland embolization: a critical appraisal.
Befeler AS
Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma].
Alvarez R; Bañares R; Echenagusía A; Carneros JA; Santos L; Simó G; Camúñez F
Gastroenterol Hepatol; 2000 Apr; 23(4):153-8. PubMed ID: 10863854
[TBL] [Abstract][Full Text] [Related]
16. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
Liu Y; Yang R
J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
[TBL] [Abstract][Full Text] [Related]
17. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
[TBL] [Abstract][Full Text] [Related]
18. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
19. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
Kim JH; Won HJ; Shin YM; Kim SH; Yoon HK; Sung KB; Kim PN
Ann Surg Oncol; 2011 Jun; 18(6):1624-9. PubMed ID: 21445671
[TBL] [Abstract][Full Text] [Related]
20. Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma.
Graf H; Jüngst C; Straub G; Dogan S; Hoffmann RT; Jakobs T; Reiser M; Waggershauser T; Helmberger T; Walter A; Walli A; Seidel D; Goke B; Jüngst D
Digestion; 2008; 78(1):34-8. PubMed ID: 18797167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]